Publications by authors named "Kay Klausing"

Claim this Profile
B
Biological characterization of a heterodimer-selective retinoid X receptor modulator: potential benefits for the treatment of type 2 diabetes.
Mark D Leibowitz, Robert J Ardecky, Marcus F Boehm, Carol L Broderick, Mark A Carfagna, Kay Klausing

Endocrinology· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
Anne Reifel-Miller, Keith Otto, Eric Hawkins, Robert Barr, William R Bensch, Kay Klausing

Mol Endocrinol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rosiglitazone induction of Insig-1 in white adipose tissue reveals a novel interplay of peroxisome proliferator-activated receptor gamma and sterol regulatory element-binding protein in the regulation of adipogenesis.
Heidi R Kast-Woelbern, Sharon L Dana, Rosemary M Cesario, Li Sun, Louise Y de Grandpre, Kay Klausing

J Biol Chem· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mammalian two-hybrid assay for detection of coactivator-nuclear receptor interactions.
Curtis M Tyree, Kay Klausing

Methods Mol Med· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of selective retinoid X receptor agonist-induced hypothyroidism in the rat.
Sha Liu, Kathleen M Ogilvie, Kay Klausing, Mark A Lawson, Diane Jolley

Endocrinology· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis